85-5063-52　(2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-(((E)-1,4-diacetoxy-2,5-dihydroxy-6-(2-(phthalazin-1-yl)hydrazono)hexan-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate 2.5mg　421715

特徴

• (2R,3S,4S,5R,6S)-2-(Acetoxymethyl)-6-(((E)-1,4-diacetoxy-2,5-dihydroxy-6-(2-(phthalazin-1-yl)hydrazono)hexan-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl Triacetate is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct (H675150). Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose (L114000).
• Molecular Formula:C32H40N4O16
• Solubility:Chloroform, Dichloromethane, Methanol
• Molecular Weight:736.68
• Storage and Stability:Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：2.5mg
• Grade：Highly Purified
• Form：Supplied as a Yellow Solid
• Molecular Formula：C32H40N4O16
• Molecular Weight Non Ab：736.68
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]